Health Care & Life Sciences » Biotechnology | Genetic Technologies Ltd.

Genetic Technologies Ltd. | Balance Sheet

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,834.00
18,344.90
11,183.90
10,991.60
5,490.50
Total Accounts Receivable
1,111.60
715.00
630.80
426.30
301.40
Inventories
213.00
317.50
166.90
76.80
59.00
Other Current Assets
201.90
188.70
149.50
136.90
139.80
Total Current Assets
4,360.50
19,566.10
12,131.10
11,631.60
5,990.70
Net Property, Plant & Equipment
394.20
417.60
550.10
476.60
175.30
Total Investments and Advances
795.50
-
-
-
-
Intangible Assets
1,179.00
736.00
608.50
-
-
Total Assets
6,729.20
20,719.70
13,289.70
12,108.30
8,665.80
ST Debt & Current Portion LT Debt
-
25.00
-
-
-
Accounts Payable
900.30
517.10
392.30
398.30
535.90
Other Current Liabilities
1,417.70
1,193.10
939.90
1,067.00
914.80
Total Current Liabilities
2,318.00
1,735.20
1,332.20
1,465.30
1,450.70
Long-Term Debt
2,502.40
-
-
-
-
Provision for Risks & Charges
81.30
25.30
74.30
64.00
3.40
Total Liabilities
4,901.70
1,760.50
1,406.50
1,529.30
3,953.90
Common Equity (Total)
1,827.50
18,959.20
11,883.20
10,579.00
4,711.90
Total Shareholders' Equity
1,827.50
18,959.20
11,883.20
10,579.00
4,711.90
Total Equity
1,827.50
18,959.20
11,883.20
10,579.00
4,711.90
Liabilities & Shareholders' Equity
6,729.20
20,719.70
13,289.70
12,108.30
8,665.80

About Genetic Technologies

View Profile
Address
60-66 Hanover Street
Fitzroy Victoria (VIC) 3065
Australia
Employees -
Website http://www.gtgcorporate.com
Updated 07/08/2019
Genetic Technologies Ltd. engages in the provision of molecular risk assessment for cancer. It operates through the USA and Australia geographical segments. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer.